The fourth wall
This site is a demonstration. It was built in one night, on July 7, 2026, to make an argument that is easier to show than to say.
Cost Plus Drugs publishes its actual acquisition cost plus a fixed 15% on every one of roughly 2,500 medications. That price list is usually described as a pharmacy. It is also something else: the only public, continuously updated record of what American drugs actually cost — which makes it the raw material for a publication nobody else can produce.
Researchers already treat it that way. Harvard used it to benchmark Medicare. Penn used it to benchmark employer insurance. The FTC's PBM reports document the same gap from the other direction. But those are papers, published months apart, read by specialists. Nobody has turned the dataset into what it wants to be: a running index — updated, ranked, readable — that becomes the reference the press, Congress and 340 million patients check when they want to know what a drug should cost.
Everything on this demo — the index, both briefings, the methodology — was researched, verified and shipped in one working session by Letter Leverage, an AI-native editorial studio. Every number traces to a source URL. That speed and that discipline are the product: we would build and run this publication end to end, under your brand or a neutral one, as a service.
The ask: thirty minutes. Nils Liedlich — nils@letterleverage.com. I'm at RAISE Summit both days.
One necessary disclaimer: this demonstration is not affiliated with, or endorsed by, Mark Cuban Cost Plus Drug Company. All Cost Plus prices shown were pulled from public product pages on costplusdrugs.com and are dated. If the company would rather this demo not exist, it comes down with one email.